Beneficial effect of midodrine in hypotensive cirrhotic patients with refractory ascites

Gastroenterology and Hepatology

Volumn 7, Issue 2, 2011, Pages 132-134

  Sourianarayanane, Achuthan ^a   Barnes, David S ^a,b   McCullough, Arthur J ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIDODRINE;

ADULT; ARTICLE; ASCITES; ASCITES FLUID; CASE REPORT; CHILD PUGH SCORE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PARACENTESIS; SCORING SYSTEM; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

EID: 79952795325     PISSN: 15547914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Kashani A, Landaverde C, Medici V, Rossaro L. Fluid retention in cirrhosis: pathophysiology and management. OJM. 2008;101:71-85. (Pubitemid 351234707)
2. Luca A, Garcia-Pagan JC, Bosch J, et al. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis. Hepatology. 1995;22:753-758.
3. Angeli P, Volpin R, Gerunda G, et al. Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide. Hepatology. 1999;29: 1690-1697. (Pubitemid 29247040)
4. Alessandria C, Ottobrelli A, Debernardi-Venon W, et al. Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. J Hepatol. 2007;47:499-505. (Pubitemid 47331744)
5. Kalambokis GN, Tsianos EV. Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome. Hepatology. 2008;48:686.
6. Martin PY, Gines P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med. 1998;339:533-541. (Pubitemid 28384887)
7. Prakash S, Garg AX, Heidenheim AP, House AA. Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review. Nephrol Dial Transplant. 2004;19:2553-2558. (Pubitemid 39360103)
8. Cruz DN, Mahnensmith RL, Brickel HM, Perazella MA. Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up. Clin Nephrol. 1998;50:101-107. (Pubitemid 28401002)
9. Lin YF, Wang JY, Denq JC, Lin SH. Midodrine improves chronic hypotension in hemodialysis patients. Am J Med Sci. 2003;325:256-261.
10. Perazella MA. Efficacy and safety of midodrine in the treatment of dialysis-associated hypotension. Expert Opin Drug Saf. 2003;2:37-47.
11. Young TM, Mathias CJ. Taste and smell disturbance with the alpha-adrenoceptor agonist midodrine. Ann Pharmacother. 2004;38:1868-1870. (Pubitemid 39425724)
12. Kalambokis G, Fotopoulos A, Economou M, Tsianos EV. Beneficial haemodynamic and renal sodium handling effects of combined midodrine and octreotide treatment in a cirrhotic patient with large hepatic hydrothorax and mild ascites. Nephrol Dial Transplant. 2005;20:2583. (Pubitemid 41548904)
13. Kalambokis G, Tsianos EV. Treatment of hepatic hydrothorax with vasoconstrictor drugs. Scand J Gastroenterol. 2007;42:534. (Pubitemid 46569400)
14. Pfammatter R, Quattropani C, Reichen J, Goke B, Wagner AC. Treatment of hepatic hydrothorax and reduction of chest tube output with octreotide. Eur J Gastroenterol Hepatol. 2001;13:977-980. (Pubitemid 32757020)
15. Kalambokis G, Fotopoulos A, Economou M, Tsianos EV. Octreotide in the treatment of refractory ascites of cirrhosis. Scand J Gastroenterol. 2006;41:118-121. (Pubitemid 43030900)
16. Angeli P, Volpin R, Piovan D, et al. Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites. Hepatology. 1998;28:937-943. (Pubitemid 28450253)
17. Tandon P, Tsuyuki RT, Mitchell L, et al. The effect of 1 month of therapy with midodrine, octreotide-LAR and albumin in refractory ascites: a pilot study. Liver Int. 2009;29:169-174.
18. Singh V, Dheerendra PC, Singh B, et al. Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study. Am J Gastroenterol. 2008;103:1399-1405. (Pubitemid 351813906)